Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Inclusion Criteria

• •Treated with thiazolidinedione (TZD) alone or in combination with metformin. TZD dose stable for at least 120 days prior to screening, and those patients on metformin must have been on a stable dose for at least 30 days prior to screening.
• •HbA1c between 7.1% and 10.0%, inclusive.
• •Body mass index (BMI) between 25 kg/m\^2 and 45 kg/m\^2.